keyword
Keywords Mesenchymal cell transplantati...

Mesenchymal cell transplantation Chinese

https://read.qxmd.com/read/36946345/-the-increased-expression-of-stromal-cell-derived-factor-1-sdf-1-alleviates-airway-inflammation-in-asthmatic-rats-by-promoting-the-migration-of-bone-marrow-mesenchymal-stem-cells-bmscs
#21
JOURNAL ARTICLE
Huizhi Zhu, Kun Wang, Shunzhi Zhu, Dawei Wang, Xiangguo Liu
Objective To observe the correlation of stromal cell-derived factor 1 (SDF-1) with bone marrow mesenchymal stem cell (BMSCs) migration and airway inflammation in asthmatic rats. Methods Twenty-four clean SD rats were randomly divided into normal control (NC) group, model control (MC) group, and BMSCs group. Asthma model was established by OVA. In the BMSCs group, 1×106 BMSCs (1 mL) were transplanted into the tail vein on the day the model was completed. Pathological changes in lung tissues were evaluated by HE staining...
March 2023: Xi Bao Yu Fen Zi Mian Yi Xue za Zhi, Chinese Journal of Cellular and Molecular Immunology
https://read.qxmd.com/read/36926725/injectable-collagen-scaffold-with-human-umbilical-cord-derived-mesenchymal-stem-cells-promotes-functional-recovery-in-patients-with-spontaneous-intracerebral-hemorrhage-phase-i-clinical-trial
#22
JOURNAL ARTICLE
Xiao-Yin Li, Wu-Sheng Deng, Zi-Qi Wang, Zheng-Chao Li, Shu-Lian Chen, Zhen Song, Quan Zhang, Jin Liang, Xu-Yi Chen
Animal experiments have shown that injectable collagen scaffold with human umbilical cord-derived mesenchymal stem cells can promote recovery from spinal cord injury. To investigate whether injectable collagen scaffold with human umbilical cord-derived mesenchymal stem cells can be used to treat spontaneous intracerebral hemorrhage, this non-randomized phase I clinical trial recruited patients who met the inclusion criteria and did not meet the exclusion criteria of spontaneous intracerebral hemorrhage treated in the Characteristic Medical Center of Chinese People's Armed Police Force from May 2016 to December 2020...
September 2023: Neural Regeneration Research
https://read.qxmd.com/read/36872428/-exosomes-derived-from-mesenchymal-stem-cells-loaded-with-annexin-a2-reduce-the-polarization-of-m2-macrophages-to-inhibit-the-growth-of-prostate-cancer-cells-in-nude-mice
#23
JOURNAL ARTICLE
Ye Tian, Xiaopeng Guo, Jun Cheng, Peng Wang
Objective To identify the effect of exosomes derived from bone marrow mesenchymal stem cells (BMSCs) loaded with annexin A2 (ANXA2) on the proliferation, migration, invasion of prostate cancer cells, and the transplanted tumor of prostate cancer in nude mice growth, as well as the role of macrophages in this process. Methods BMSCs from BALB/c nude mice were isolated and cultured. BMSCs were infected with lentiviral plasmids loaded with ANXA2. Exosomes were isolated and then added to treat THP-1 macrophages...
February 2023: Xi Bao Yu Fen Zi Mian Yi Xue za Zhi, Chinese Journal of Cellular and Molecular Immunology
https://read.qxmd.com/read/36703021/human-umbilical-cord-blood-derived-mesenchymal-stem-cell-transplantation-for-patients-with-decompensated-liver-cirrhosis
#24
JOURNAL ARTICLE
Zepeng Li, Xiaoling Zhou, Lu Han, Meijie Shi, Huanming Xiao, Ming Lin, Xiaoling Chi
BACKGROUND OR PURPOSE: Although human umbilical cord blood-derived mesenchymal stem cell transplantation (HUCB-MSCT) resulted in a good short-term therapeutic effect on patients with decompensated liver cirrhosis (DLC), the long-term survival remained unclear. This study aimed to evaluate the impact of HUCB-MSCT on long-term outcomes in patients with DLC. METHODS: This retrospective cohort study included hospitalized patients with decompensated cirrhosis in Liuzhou Hospital of Traditional Chinese Medicine between November 2010 and February 2013...
January 26, 2023: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/36684056/roles-of-conventional-and-complementary-therapies-in-recurrent-hepatocellular-carcinoma
#25
REVIEW
Hsiang-Chun Lai, Hung-Jen Lin, Long-Bin Jeng, Sheng-Teng Huang
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and the fourth leading cause of cancer-related deaths in the world. HCC has a reported recurrence rate of 70%-80% after 5 years of follow-up. Controlling tumor recurrence is the most critical factor associated with HCC mortality. Conventional salvage therapies for recurrent HCC include re-hepatectomy or liver transplantation, transcatheter arterial chemoembolization, Y-90, target therapy, and immunotherapy; however, these conventional treatment modalities have yet to achieve consistently favorable outcomes...
January 15, 2023: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/36283750/autologous-cultured-adipose-derived-mesenchymal-stem-cells-combined-with-hyaluronic-acid-hydrogel-in-the-treatment-of-discogenic-low-back-pain-a-study-protocol-for-a-phase-ii-randomised-controlled-trial
#26
JOURNAL ARTICLE
Jing Zhang, Tianze Sun, Wentao Zhang, Ming Yang, Zhonghai Li
INTRODUCTION: Discogenic low back pain (DLBP) is a common disease, and its occurrence is closely related to intervertebral disc (IVD) degeneration. At present, none of the traditional treatment methods can repair the degenerated IVD. The emergence of stem cell therapy makes it possible to repair and regenerate IVD tissue, among which adipose derived mesenchymal stem cells (ADMSCs) transplantation therapy has become a hot spot of current research. Therefore, this trial aimed to investigate the safety and efficacy of using autologous cultured ADMSCs combined with hyaluronic acid (HA) hydrogel in the treatment of DLBP...
October 25, 2022: BMJ Open
https://read.qxmd.com/read/35922850/astragalus-mongholicus-bunge-and-curcuma-aromatica-salisb-inhibits-liver-metastasis-of-colon-cancer-by-regulating-emt-via-the-cxcl8-cxcr2-axis-and-pi3k-akt-mtor-signaling-pathway
#27
JOURNAL ARTICLE
Fuyan Liu, Yan Liang, Ruolan Sun, Weicheng Yang, Zhongqing Liang, Junfei Gu, Fan Zhao, Decai Tang
BACKGROUND: One of the most challenging aspects of colon cancer (CC) prognosis and treatment is liver-tropic metastasis. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. (AC) is a typical medication combination for the therapy of many malignancies. Our previous studies found that AC intervention inhibits liver metastasis of colon cancer (LMCC). Nevertheless, the comprehensive anti-metastasis mechanisms of AC have not been uncovered. METHODS: In bioinformatics analysis, RNA-seq data of CC and LMCC patients were collected from TCGA and GEO databases, and differentially expressed genes (DEGs) were identified...
August 3, 2022: Chinese Medicine
https://read.qxmd.com/read/35907648/jujuboside-a-inhibits-oxidative-stress-damage-and-enhances-immunomodulatory-capacity-of-human-umbilical-cord-mesenchymal-stem-cells-through-up-regulating-ido-expression
#28
JOURNAL ARTICLE
Ji-Cong Chen, Hong-He Xiao, Qiang Zhang, Liang Kong, Tian-Min Wang, Yu Tian, Yu-Meng Zhao, He Li, Jin-Ming Tian, Cui Wang, Jing-Xian Yang
Impaired immunomodulatory capacity and oxidative stress are the key factors limiting the effectiveness of mesenchymal stem cell transplantation therapy. The present study was aimed to investigate the effects of jujuboside A (JuA) on the protective effect and immunomodulatory capacity of human umbilical cord mesenchymal stem cells (hUC-MSCs). Hydrogen peroxide was used to establish an oxidative damage model of hUC-MSCs, while PBMCs isolated from rats were used to evaluate the effect of JuA pre-treatment on the immunomodulatory capacity of hUC-MSCs...
July 2022: Chinese Journal of Natural Medicines
https://read.qxmd.com/read/35842684/one-year-follow-up-study-after-patients-with-severe-covid-19-received-human-umbilical-cord-mesenchymal-stem-cells-treatment
#29
JOURNAL ARTICLE
Lei Shi, You Zheng, Zhi Cheng, Ningfei Ji, Changming Niu, Yan Wang, Tingrong Huang, Ruyou Li, Mao Huang, Xiaolin Chen, Lei Shu, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan, Ganzhu Feng
BACKGROUND: The novel coronavirus is still mutating, and the pandemic continues. Meanwhile, many COVID-19 survivors have residual postinfection clinical manifestations. Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been shown to be effective in the early stages of COVID-19. OBJECTIVES: The aim of this study was to investigate long-term safety and efficacy of treatment in patients with severe COVID-19 patients who had received hUC-MSCs therapy. METHODS: Twenty-five discharged patients who had severe COVID-19 (including the standard treatment group and the standard treatment plus hUC-MSCs group) were enrolled in a 1-year follow-up...
July 16, 2022: Stem Cell Research & Therapy
https://read.qxmd.com/read/35764589/-research-advances-on-mesenchymal-stem-cells-and-their-derivatives-in-the-treatment-of-acne-scars
#30
JOURNAL ARTICLE
F Li, Y Cai, C L Deng
Acne is a common chronic inflammatory disease of the skin that often occurs on the face, and acne scars are often secondary to the healing process of acne, which often leads to impaired appearance and psychological disorders of patients. The current treatment for acne scars is extremely difficult. With the development of regenerative medicine, stem cell transplantation has become a new treatment for acne scars. In recent years, it has been reported that stem cells and their derivatives can effectively antagonize the formation of acne scars...
June 20, 2022: Zhonghua Shao Shang za Zhi, Zhonghua Shaoshang Zazhi, Chinese Journal of Burns
https://read.qxmd.com/read/35692030/-the-research-progress-of-mesenchymal-stem-cell-induction-and-differentiation-into-corneal-tissue
#31
JOURNAL ARTICLE
J J Liu, L L Wang, Y F Huang
Keratopathy is one of the most important blinding eye diseases in the world. Corneal opacity caused by keratopathy can seriously damage visual function. For example, corneal ulcer can lead to perforation and even loss of the eyeball. Although corneal transplantation is a routine treatment in clinical practice, there are not only a serious shortage of corneal donors in our country, but also various complications after keratoplasty that can not be avoided. In recent years, with the rapid development of regenerative medicine, it has been found that mesenchymal stem cells can differentiate into a variety of functional cells including corneal tissue under suitable induction conditions, which has a broad prospect of clinical application...
June 11, 2022: [Zhonghua Yan Ke za Zhi] Chinese Journal of Ophthalmology
https://read.qxmd.com/read/35599418/-effects-of-non-muscle-myosin-%C3%A2-silenced-bone-marrow-derived-mesenchymal-stem-cells-transplantation-on-lung-extracellular-matrix-in-rats-after-endotoxin-lipopolysaccharide-induced-acute-lung-injury
#32
JOURNAL ARTICLE
X Yin, W F Zhou, W J Hou, M Z Fan, G S Wu, X B Liu, Q M Ma, Y S Wang, F Zhu
Objective: To investigate the effects of non-muscle myosin Ⅱ ( NMⅡ ) gene silenced bone marrow-derived mesenchymal stem cells (BMMSCs) on pulmonary extracellular matrix (ECM) and fibrosis in rats with acute lung injury (ALI) induced by endotoxin/lipopolysaccharide (LPS). Methods: The experimental research methods were adopted. Cells from femur and tibial bone marrow cavity of four one-week-old male Sprague-Dawley rats were identified as BMMSCs by flow cytometry, and the third passage of BMMSCs were used in the following experiments...
May 20, 2022: Zhonghua Shao Shang za Zhi, Zhonghua Shaoshang Zazhi, Chinese Journal of Burns
https://read.qxmd.com/read/35505375/efficacy-and-safety-of-umbilical-cord-derived-mesenchymal-stem-cells-in-chinese-adults-with-type-2-diabetes-a-single-center-double-blinded-randomized-placebo-controlled-phase-ii-trial
#33
RANDOMIZED CONTROLLED TRIAL
Li Zang, Yijun Li, Haojie Hao, Jiejie Liu, Yu Cheng, Bing Li, Yaqi Yin, Qian Zhang, Fei Gao, Haibin Wang, Shi Gu, Jia Li, Fengxiang Lin, Yingfei Zhu, Guanglei Tian, Yulong Chen, Weijun Gu, Jin Du, Kang Chen, Qinghua Guo, Guoqing Yang, Yu Pei, Wenhua Yan, Xianling Wang, Junhua Meng, Saichun Zhang, Jianming Ba, Zhaohui Lyu, Jingtao Dou, Weidong Han, Yiming Mu
BACKGROUND: To determine the efficacy and safety of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in Chinese adults with type 2 diabetes mellitus (T2DM). METHODS: In this single-center, double-blinded, randomized, placebo-controlled phase II trial, 91 patients were randomly assigned to receive intravenous infusion of UC-MSCs (n = 45) or placebo (n = 46) three times with 4-week intervals and followed up for 48 weeks from October 2015 to December 2018...
May 3, 2022: Stem Cell Research & Therapy
https://read.qxmd.com/read/35462479/-research-advances-in-the-treatment-of-liver-failure-with-mesenchymal-stem-cell-derived-exosomes
#34
JOURNAL ARTICLE
Q M Luo, S Zhu, L Peng, Z L Gao
Liver failure is a serious clinical syndrome in which multiple pathogenic factors exceed the liver's self-repair capability, resulting massive hepatocellular necrosis, rapid disease progression and high mortality. Liver transplantation is the most effective method for the treatment of liver failure, but it has disadvantages, such as insufficient liver donor and high cost. The clinical efficacy of mesenchymal stem cells in liver failure have been validated, but its application has been limited to certain extent...
March 20, 2022: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/35462477/-clinical-research-in-cell-therapy-of-liver-diseases-progress-and-challenges
#35
JOURNAL ARTICLE
L Shi, Z R Wang, T T Li, E Q Linghu, F S Wang
The high incidence of chronic liver disease is a serious threat to public health, and the current comprehensive internal medicine treatment is ineffective. Liver transplantation is limited by the shortage of liver source and post-transplant rejection, and thus unmet the clinical needs. More importantly, cell therapy shows great promise for the treatment of chronic liver disease. Over recent years, domestic and foreign scholars have carried out a variety of cell therapy preclinical and clinical trials for critical liver disease, and achieved certain results, providing new methods for the treatment of chronic liver diseases...
March 20, 2022: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/35371265/efficacy-and-safety-of-mesenchymal-stem-cell-transplantation-in-the-treatment-of-autoimmune-diseases-rheumatoid-arthritis-systemic-lupus-erythematosus-inflammatory-bowel-disease-multiple-sclerosis-and-ankylosing-spondylitis-a-systematic-review-and-meta-analysis
#36
JOURNAL ARTICLE
Liuting Zeng, Ganpeng Yu, Kailin Yang, Wang Xiang, Jun Li, Hua Chen
Objective: To evaluate the efficacy and safety of mesenchymal stem cell (MSC) transplantation in the treatment of autoimmune diseases. Methods: The Chinese and English databases were searched for clinical research on the treatment of autoimmune diseases with mesenchymal stem cells. The search time range is from a self-built database to October 1, 2021. Two reviewers independently screened the literature according to the inclusion and exclusion criteria, extracted data, and evaluated the bias of the included studies...
2022: Stem Cells International
https://read.qxmd.com/read/34865351/-effect-of-basic-fibroblast-growth-factor-treatment-on-efficacy-of-adipose-derived-mesenchymal-stem-cells-in-liver-cirrhosis
#37
JOURNAL ARTICLE
W P Tang, Q Hu, G D Chen, J X Luo
Objective: To observe the effect of basic fibroblast growth factor (bFGF) treatment on efficacy of adipose-derived mesenchymal stem cells (ADSCs) in cirrhotic rats. Methods: A rat model of liver cirrhosis was established via intraperitoneal injection of carbon tetrachloride (CCl(4)) for 10 weeks. Thirty SD rats were randomly divided into 3 groups ( n = 10): control group served as group A, and 0.5ml of phosphate-buffered saline (PBS) was transfused into the tail vein; ADSCs single-dose transplantation group served as group B, and 1×10(6) ADSCs were transplanted into the tail vein; bFGF-treated ADSCs treatment group served as group C, and 1×10(6) bFGF-treated ADSCs were transplanted through tail vein...
December 20, 2020: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/34656420/the-safety-and-efficacy-of-mesenchymal-stem-cell-therapy-in-diabetic-lower-extremity-vascular-disease-a-meta-analysis-and-systematic-review
#38
REVIEW
Lewei Jin, Xiancheng Wang, Zhihua Qiao, Yiwen Deng
BACKGROUND AIMS: Several studies have shown the efficacy of mesenchymal stem cell (MSC) therapy for lower extremity vascular disease (LEVD) in diabetic patients, but the results are not consistent. Therefore, the authors conducted a meta-analysis of randomized controlled trials (RCTs) to examine the safety and efficacy of MSC therapy in diabetic patients with LEVD. METHODS: Eight available databases were searched in both English and Chinese to identify RCTs comparing MSC therapy-based conventional treatment with conventional treatment alone in diabetic patients with LEVD...
October 13, 2021: Cytotherapy
https://read.qxmd.com/read/34583247/dendrobium-officinale-polysaccharide-induced-neuron-like-cells-from-bone-marrow-mesenchymal-stem-cells-improve-neuronal-function-a-rat-stroke-model
#39
JOURNAL ARTICLE
Rengang Dou, Xue Liu, Xiuli Kan, Xianshan Shen, Jing Mao, Hongtao Shen, Jianxian Wu, Hanlin Chen, Wanting Xu, Shasha Li, Tingting Wu, Yongfeng Hong
Various methods have been used to induce the neuronal differentiation of marrow mesenchymal stem cells (MSCs). However, the limited induction efficiency of cells in vitro has restricted their use. Therefore, identifying a simple and efficient treatment method is necessary. Dendrobium officinale is an important traditional Chinese medicine, and its main component, polysaccharides, has many pharmacological activities. However, the effects of D. officinale polysaccharide (DOP) on the neuronal differentiation of bone marrow mesenchymal stem cells (BMSCs) and treatment of ischaemic stroke remain unknown...
September 17, 2021: Tissue & Cell
https://read.qxmd.com/read/34492537/a-novel-study-on-the-immunomodulatory-effect-of-umbilical-cord-derived-mesenchymal-stem-cells-pretreated-with-traditional-chinese-medicine-asarinin
#40
JOURNAL ARTICLE
Haiping He, Tonghua Yang, Fan Li, Lihua Zhang, Xiaosui Ling
Allogeneic hematopoietic stem cell transplantation (HSCT) remains the key for the treatment of malignant hematological diseases, and acute graft-versus-host disease (aGVHD) that might occur after allogenic transplantation can be life threatening and promote disease recurrence. GVHD damages the various parts of the body by upregulating T helper 1 cytokines (Th1) cytokines and stimulating CD4、CD8 + T cells. GVHD can exhibit significant immunoregulatory effects, but could be easily affected by the mesenchymal stem cells (MSC) environment, and hence the MSC immunosuppressive effects on GVHD remain unpredictable...
September 3, 2021: International Immunopharmacology
keyword
keyword
120197
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.